We examine the rise and risks of blockbuster drugs like Ozempic, after the WHO conditionally recommended GLP-1 medications for the long-term treatment of obesity. »»» Subscribe to CBC News to watch more videos: http://bit.ly/1RreYWS For breaking news, video, audio and in-depth coverage: https://www.cbc.ca/news Follow CBC News on TikTok: https://www.tiktok.com/@cbcnews Subscribe to CBC News on Snapchat: https://bit.ly/3leaWsr Download the CBC News app for iOS: http://apple.co/25mpsUz Download